Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Bayer CV Pact Gives AI-Focused Sensyne Health Its First Big Deal Since 2018 IPO

Wed, 07/31/2019 - 8:21am

The UK-based group will help Bayer accelerate clinical development of new treatments for cardiovascular disease using Sensyne Health’s clinical AI...

      Related Stories 

Takeda Raises Guidance On Divestments, Improved Velcade Outlook

Tue, 07/30/2019 - 11:41pm

Takeda raises its guidance for both revenue growth and core profit after its first full fiscal quarter since acquiring Shire...

      Related Stories 

Wellington Partners Unveils €210m Eurocentric Biotech:Medtech Fund WPLS-V

Tue, 07/30/2019 - 9:06pm

With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V...

      Related Stories 

Strides Fast-Tracks China Entry With JV As It Reports Strong Q1

Tue, 07/30/2019 - 6:31pm

Indian firm Strides announces its entry into China through a joint venture with one of the country’s leading pharmaceutical firms...

      Related Stories 

Q2 Review: Big Pharmas Weigh In On M&A, Pricing Reform

Tue, 07/30/2019 - 3:29pm

As earnings season reaches its peak, Merck, Lilly, Gilead, Amgen and Sanofi release their second quarter results. Business development remains...

      Related Stories 

Tech Transfer Roundup: Anixa Thinks Cleveland Clinic IP Offers Potential In Triple-Negative Breast Cancer

Tue, 07/30/2019 - 12:43pm

Anixa obtains cancer vaccine targeted to proteins common in breast cancer from Cleveland Clinic. Arxx licenses Cancer Research UK antibody...

      Related Stories 

Janssen And ViiV: Giving HIV/AIDS Patients Options Is Key

Tue, 07/30/2019 - 8:36am

With EU submissions for once-monthly long-acting  anti-HIV antivirals in hand, Janssen and ViiV appear to have set their sights on...

      Related Stories 

Latest Phase II Data Bolster Cidara’s Antifungal

Tue, 07/30/2019 - 8:36am

Cidara Therapeutics said new top-line results from the Phase II trial evaluating its lead asset as a first-line antifungal treatment...

      Related Stories 

Honjo, Ono Remain At Loggerheads As Opdivo Dispute Simmers

Mon, 07/29/2019 - 5:06pm

PD-1 discoverer and the Japanese co-developer of Opdivo remain locked in simmering dispute over patent royalties, with a revised one-off...

      Related Stories 

At Pfizer, A Split A Decade In The Making

Mon, 07/29/2019 - 1:24pm

Pfizer's ambitious plans to spin out its Upjohn branded and generics business will result in a smaller, innovation-focused pharma. The...

      Related Stories 

Sanofi And Lexicon Fall Out Over Zynquista, As French Group Exits Diabetes Pact

Mon, 07/29/2019 - 8:13am

Lexicon labelled Sanofi’s unilateral decision to exit their alliance ‘invalid’ and said the French drugmaker was thus ‘in breach of...

      Related Stories 

Pages